Related Experiment Video

Updated: Jun 10, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

A magnetization transfer study of mild and advanced Parkinson's disease

N Tambasco1, V Belcastro, P Sarchielli

  • 1Clinica Neurologica, Azienda Ospedaliera - Università di Perugia, Italy. n.tambasco@libero.it

European Journal of Neurology
|August 21, 2010
PubMed
Abstract

Insights

Magnetization transfer ratio (MTR) reveals distinct brain tissue changes in early and advanced Parkinson's disease (PD). MTR reductions progress to new areas as PD advances, reflecting disease-related morphological alterations.

Area of Science:

  • Neuroimaging
  • Neurodegenerative Diseases
  • Biomarkers

Background:

  • Magnetization transfer ratio (MTR) detects brain alterations in Parkinson's disease (PD), including early stages.
  • The progression of these tissue changes throughout PD is not well understood.

Purpose of the Study:

  • To investigate how MTR values change from mild PD (PD1) to advanced PD (PD2).
  • To differentiate MTR changes across different stages of Parkinson's disease progression.

Main Methods:

  • MTR values were measured using region of interest analysis.
  • Participants included 11 patients with mild PD (PD1), 11 with advanced PD (PD2), and 10 healthy controls.

Main Results:

  • Mild PD (PD1) showed significant MTR reduction in substantia nigra, putamen, and specific white matter regions compared to controls.
  • Advanced PD (PD2) exhibited additional MTR reductions in the caudate, pons, frontal white matter, and lateral thalamus.

Conclusions:

  • MTR changes appear to reflect disease-specific morphological alterations in distinct brain areas.
  • MTR may serve as a sensitive imaging biomarker for tracking Parkinson's disease progression.

More Related Videos

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease10:32

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...